The presence of consensus Gli DNA-binding sequences in the sequence of Cyclin D1 and cyclin D2 genes, and the fact that Gli1 binds to cyclin D2 promoter [33], suggest that Gli1 and Gli2 modulate NSCLC proliferation by directly regulating cyclin D expression. The gene discussed is CCND2; the disease is non-small cell lung carcinoma.